Template:Mastitis antibiotics: Difference between revisions

Revision as of 21:51, 18 January 2019

No need to routinely interrupt breastfeeding with puerperal mastitis.
For mild symptoms <24 hours, supportive care may be sufficient^[1]
- Effective milk removal (frequent breast feeding - use pumping to augment milk removal)
- Analgesia (NSAIDs)

Treatment directed at S. aureus and Strep and E. coli

Uncomplicated mastitis → 10 days of antibiotics (regardless of MRSA suspicion)^[2]
Dicloxacillin 500mg PO q6hrs, considered first line if breastfeeding given safety for infant OR
Cephalexin 500mg PO q6hrs OR
- Add TMP/SMX 2DS tabs PO q12hrs if suspect MRSA
Clindamycin 450mg PO q8hrs (also provides MRSA coverage) OR
Amoxicillin/Clavulanate 875mg PO q12hrs OR
Azithromycin 500mg PO x1 on day 1, then 250mg PO daily for days 2-5

↑ Amir LH. ABM Clinical Protocol #4: Mastitis, Revised March 2014. Breastfeeding Medicine. 2014;9(5):239-243. doi:10.1089/bfm.2014.9984.
↑ Levine BL. 2011 EMRA Antibiotic Guide. EMRA. Pg 78.

@@ Line 5: / Line 5: @@
 ===[[Antibiotics]]===
-''Treatment directed at [[S. aureus]] and [[Strep]] and [[E. coli]]''
+{{Mastitis antibiotic}}
-*Uncomplicated mastitis → 10 days of antibiotics (regardless of [[MRSA]] suspicion)<ref>Levine BL. 2011 EMRA Antibiotic Guide. EMRA. Pg 78.</ref>
-*[[Dicloxacillin]] 500mg PO q6hrs, considered first line if breastfeeding given safety for infant '''OR'''
-*[[Cephalexin]] 500mg PO q6hrs '''OR'''
-**Add [[TMP/SMX]] 2DS tabs PO q12hrs if suspect [[MRSA]]
-*[[Clindamycin]] 450mg PO q8hrs (also provides MRSA coverage) '''OR'''
-*[[Amoxicillin/Clavulanate]] 875mg PO q12hrs '''OR'''
-*[[Azithromycin]] 500mg PO x1 on day 1, then 250mg PO daily for days 2-5